Association of positively selected eIF3a polymorphisms with toxicity of platinum-based chemotherapy in NSCLC patients

被引:0
|
作者
Ji-ye Yin
Xiang-guang Meng
Chen-yue Qian
Xiang-ping Li
Juan Chen
Yi Zheng
Rong Liu
Hong-hao Zhou
Zhao-qian Liu
机构
[1] Xiangya Hospital,Department of Clinical Pharmacology
[2] Central South University,Department of Pharmacy
[3] Institute of Clinical Pharmacology,undefined
[4] Central South University,undefined
[5] Hunan Key Laboratory of Pharmacogenetics,undefined
[6] Hunan Province Cooperation Innovation Center for Molecular Target New Drug Study,undefined
[7] Laboratory of Cardiovascular Disease and Drug Research,undefined
[8] Zhengzhou No 7 People's Hospital,undefined
[9] Zhengzhou 450016,undefined
[10] China,undefined
[11] Xiangya Hospital,undefined
[12] Central South University,undefined
来源
关键词
eIF3a; positive selection; polymorphism; lung cancer; platinum-based chemotherapy; chemotherapy toxicity; Chinese NSCLC patients;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:375 / 384
页数:9
相关论文
共 50 条
  • [1] Association of positively selected eIF3a polymorphisms with toxicity of platinum-based chemotherapy in NSCLC patients
    Yin, Ji-ye
    Meng, Xiang-guang
    Qian, Chen-yue
    Li, Xiang-ping
    Chen, Juan
    Zheng, Yi
    Liu, Rong
    Zhou, Hong-hao
    Liu, Zhao-qian
    [J]. ACTA PHARMACOLOGICA SINICA, 2015, 36 (03) : 375 - 384
  • [2] Effect of eIF3a on Response of Lung Cancer Patients to Platinum-Based Chemotherapy by Regulating DNA Repair
    Yin, Ji-Ye
    Shen, Jie
    Dong, Zi-Zheng
    Huang, Qiong
    Zhong, Mei-Zuo
    Feng, De-Yun
    Zhou, Hong-Hao
    Zhang, Jian-Ting
    Liu, Zhao-Qian
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (13) : 4600 - 4609
  • [3] Molecular basis of eIF3a gene in therapeutic response of lung cancer patients to platinum-based chemotherapy
    Yin, Ji-ye
    Xu, Xiao-jing
    Zhou, Hong-hao
    Liu, Zhao-qian
    [J]. ACTA PHARMACOLOGICA SINICA, 2013, 34 : 18 - 18
  • [4] Novel Association Between CD74 Polymorphisms and Hematologic Toxicity in Patients With NSCLC After Platinum-Based Chemotherapy
    Tan, Xiaoming
    Wu, Qihan
    Cai, Yanyan
    Zhao, Xueying
    Wang, Shingming
    Gao, Zhiqiang
    Yang, Yang
    Li, Xiaoying
    Qian, Ji
    Wang, Jiucun
    Su, Bo
    Chen, Hongyan
    Han, Baohui
    Jiang, Gening
    Lu, Daru
    [J]. CLINICAL LUNG CANCER, 2014, 15 (01) : 67 - +
  • [5] Association of CDC25 phosphatase family polymorphisms with the efficacy/toxicity of platinum-based chemotherapy in Chinese advanced NSCLC patients
    Cai, Weijing
    Chen, Chang
    Li, Xinzheng
    Shi, Jinyun
    Sun, Qian
    Liu, Di
    Sun, Yifeng
    Hou, Likun
    Zhao, Xueying
    Gu, Shaohua
    Wu, Qihan
    Chen, Hongyan
    Zhang, Wei
    Jin, Li
    Lu, Daru
    Fei, Ke
    Su, Bo
    Qian, Ji
    [J]. FUTURE ONCOLOGY, 2014, 10 (07) : 1175 - 1185
  • [6] The A/G allele of eIF3a rs3740556 predicts platinum-based chemotherapy resistance in lung cancer patients
    Xu, Xiaojing
    Han, Lifang
    Yang, Huaping
    Duan, Li
    Zhou, Boting
    Zhao, Yingchun
    Qu, Jian
    Ma, Rui
    Zhou, Honghao
    Liu, Zhaoqian
    [J]. LUNG CANCER, 2013, 79 (01) : 65 - 72
  • [7] Prediction models for platinum-based chemotherapy response and toxicity in advanced NSCLC patients
    Yin, Ji-Ye
    Li, Xi
    Li, Xiang-Ping
    Xiao, Ling
    Zheng, Wei
    Chen, Juan
    Mao, Chen-Xue
    Fang, Chao
    Cui, Jia-Jia
    Guo, Cheng-Xian
    Zhang, Wei
    Gao, Yang
    Zhang, Chun-Fang
    Chen, Zi-Hua
    Zhou, Hui
    Zhou, Hong-Hao
    Liu, Zhao-Qian
    [J]. CANCER LETTERS, 2016, 377 (01) : 65 - 73
  • [8] Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy
    Ren, Shengxiang
    Zhou, Songwen
    Wu, Fengyin
    Zhang, Ling
    Li, Xuefei
    Zhang, Jie
    Xu, Jianfang
    Lv, Meijun
    Zhang, Jie
    Zhou, Caicun
    [J]. LUNG CANCER, 2012, 75 (01) : 102 - 109
  • [9] Pharmacogenomics of platinum-based chemotherapy in NSCLC
    Hildebrandt, Michelle A. T.
    Gu, Jian
    Wu, Xifeng
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2009, 5 (07) : 745 - 755
  • [10] Association between eIF3α polymorphism and severe toxicity caused by platinum-based chemotherapy in non-small cell lung cancer patients
    Xu, Xiaojing
    Han, Lifang
    Duan, Li
    Zhao, Yingchun
    Yang, Huaping
    Zhou, Boting
    Ma, Rui
    Yuan, Ruixia
    Zhou, Honghao
    Liu, Zhaoqian
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (02) : 516 - 523